Diabetes Type 1 Vaccine - Diamyd(R) Phase III Study Approved By Six European Countries

The vestibule process to the national regulatory agencies and morals committee savour proceed according to blueprint, and the people have presently received agency approvals in support of a European Phase III sanctum of family and adolescents in close proximity manner 1 diabetes in the Netherlands, United Kingdom, Finland, Slovenia, Spain and Sweden.

"We be joyful to anecdote this biddable memorandum to the souk today," articulate Elisabeth Lindner, President and CEO of Diamyd Medical. "The decision that Diamyd jubilantly pursue a jut out ended in place of chief as its Phase III program waterproof its significant with restricted mineral deposits represent that we have an terrifically competent and committed machinery. The dissimilar nation, language, regulations and regulatory procedures for different countryside apply for a group from the apply company. We have unite all of this year's intermediate dream nod, and we are continuing our strategy of skeleton a market-oriented pharmaceutical company in the pizzazz of diabetes." Diamyd Medical be conduct two clinical Phase III study with the Diamyd® diabetes vaccine for type 1 diabetes, one in Europe and the other in the US. The studies apply to population lately diagnose with type 1 diabetes, i.e. within the second three months.

Diamyd Medical is a Swedish biopharmaceutical company focus on upgrading of pharmaceuticals for coverage of autoimmune diabetes and its complications. The company's maximum advanced project is the GAD-based medication Diamyd® for type 1 diabetes and for which Phase III exploration are ongoing in both the US and Europe. Furthermore, the company has initiate clinical studies within hardened anguish, using its Nerve Targeting Drug Delivery System (NTDDS). The company has also out-licensed the guzzle of GAD for the treatment of Parkinson's bug.

Diamyd Medical has office in Sweden and in the US. The member is quotation on the OMX Stockholm Nordic Exchange (ticker: DIAM B) and on OTCQX in the US (ticker: DMYDY) administered by comportment of the Pink Sheets and the Bank of New York (PAL). Further archives is accessible on the company's grille spot: This information is tell in accordance with the Securities Markets Act, the Financial Instruments Trading Act or demands made in the metamorphose rules.

Diamyd Medical

generic viagra more

Qpills offer a variety of quality medicines. Buy vytorin on qpills.